StockVS

Medifast, Inc. (MED) स्टॉक विश्लेषण

चक्रीय उपभोक्ता

Medifast, Inc.

$13.09

+$0.50 (+3.97%)

अंतिम अपडेट: 26 मई 2026

प्राइस हिस्ट्री

विश्लेषण

कंपनी का अवलोकन

Medifast, Inc. operates as a health and wellness enterprise dedicated to providing habit-based and coach-guided lifestyle solutions designed to address weight loss needs within the United States market. The company functions within the Consumer Cyclical sector, specifically classified under the Personal Services industry, which characterizes its business model as dependent on consumer spending patterns and discretionary income. This entity employs a workforce of 380 individuals and holds a total market capitalization of $112.63 million, reflecting its status as a mid-sized public corporation. Its annual revenue over the trailing twelve months stands at $385.79 million, a figure that places the company in a specific tier of the personal services landscape, indicating a significant but not dominant market position relative to larger conglomerates.

वित्तीय स्वास्थ्य

The company reported a revenue of $385.79 million for the trailing twelve months, yet this generated a net income of -$18.672 million, revealing a substantial gap that points to a high cost structure or significant operational expenses eroding profitability. Despite the net loss, the entity reported an EBITDA of $29.00 million, suggesting that while accounting for non-cash items and interest, the core operational cash generation remains positive before tax and interest obligations. The firm generated free cash flow of $5.41 million, which provides a degree of financial flexibility to fund operations or reduce debt without immediate reliance on external equity financing. Analysis of the margins shows a gross margin of 71.3%, indicating strong pricing power or low cost of goods sold, contrasted sharply by an operating margin of -10.4% and a profit margin of -4.8% that reflect heavy overhead costs or restructuring charges impacting bottom-line earnings. On the balance sheet, the company holds $167.27 million in cash against $10.69 million in debt, creating a net cash position, while a debt-to-equity ratio of 5.38 suggests a technically high leverage metric that must be viewed in the context of the substantial cash reserves available to service obligations. The current ratio stands at 4.69, a metric that indicates robust short-term liquidity and the ability to cover current liabilities with current assets well more than four times over. Furthermore, the return on equity is -9.1% and the return on assets is -3.3%, metrics that reveal that management is currently generating negative returns on the capital invested by shareholders and the total asset base, respectively, signaling a need for operational improvement to convert existing assets into profitable earnings.

मूल्यांकन आकलन

The valuation metrics present a complex picture with a trailing P/E ratio listed as N/A due to negative earnings, while the forward P/E stands at -3.70, implying that the market expects earnings to improve in the future to reach a positive multiple. The price-to-book ratio is 0.53, indicating that the market values the company at approximately half of its book value, which often suggests the stock is trading at a discount relative to its tangible assets or that the market anticipates future challenges. Additionally, the price-to-sales ratio is 0.29, and the EV/EBITDA multiple is -1767.94, figures that suggest the valuation is currently driven more by revenue metrics than earnings multiples due to the loss-making status. The stock's recent price action shows a 52-week high of $15.46 and a 52-week low of $9.22, meaning the current trading price sits at a level that reflects significant volatility and downside pressure relative to its recent peak performance. The beta value is 0.56, which indicates that the stock price is less volatile than the broader market, moving with lower intensity compared to the overall index.

Growth & Income

The revenue growth year-over-year is recorded at -36.9%, while earnings growth is N/A due to the current lack of positive net income, indicating that the company is in a contraction phase regarding top-line sales. Since the earnings growth is not applicable due to losses, the disparity between shrinking revenue and negative earnings highlights a challenging period where revenue decline is directly impacting profitability without a separate earnings acceleration. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company currently reinvests its limited cash flows and retains earnings into growth initiatives rather than distributing income to shareholders. The overall growth and income profile is characterized by significant revenue contraction and a complete absence of dividend distributions, reflecting a strategic focus on survival and potential future expansion rather than current shareholder yield or consistent earnings growth.

समकक्ष तुलना

Medifast, Inc. (MED) व्यक्तिगत सेवाएं उद्योग में कार्यरत है। बाजार पूंजीकरण के आधार पर इसके निकटतम समकक्षों से तुलना इस प्रकार है:

कंपनी टिकर मार्केट कैप P/E अनुपात
Medifast, Inc. MED $145.55M N/A
Rollins, Inc. ROL $25.74B 49.0
Service Corporation International SCI $10.58B 20.2
H&R Block, Inc. HRB $4.92B 7.0

व्यक्तिगत सेवाएं उद्योग का औसत P/E अनुपात 14.9x है। Medifast, Inc. का P/E अनुपात N/A है।

यह विश्लेषण AI द्वारा केवल सूचनात्मक उद्देश्यों के लिए तैयार किया गया है और यह वित्तीय सलाह नहीं है। डेटा में देरी या अशुद्धि हो सकती है। निवेश निर्णय लेने से पहले हमेशा अपना शोध करें और किसी योग्य वित्तीय सलाहकार से परामर्श लें।

Medifast, Inc. के बारे में

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

कंपनी विवरण अंग्रेजी में दिखाया गया है।

वेबसाइट देखें →

मुख्य आंकड़े

मार्केट कैप
$145.55M
P/E अनुपात
N/A
52 सप्ताह उच्च
$15.46
52 सप्ताह निम्न
$9.22
औसत वॉल्यूम
235.09K
बीटा
0.57

डेटा yfinance के माध्यम से Yahoo Finance द्वारा प्रदान किया गया है। दैनिक अपडेट।

कंपनी जानकारी

एक्सचेंज
NYSE
देश
United States
कर्मचारी
380